The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Uger Robert since 2021.
This trader's CIK number is 1838047.
At the time of last reporting, Uger Robert was the Chief Scientific Officer of Trillium Therapeutics Inc.. (stock ticker symbol TRIL).
Also see all insider trading activities at Trillium Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | TRIL | 0 | $0 | 41,041 | $495,412 | 41,041 | $100,694 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-07-07 | TRIL | Option Ex | 3,646 | .30 | 1,108 |
| 2021-07-07 | TRIL | Sale | 3,646 | 9.00 | 32,814 |
| 2021-06-07 | TRIL | Option Ex | 3,646 | .32 | 1,148 |
| 2021-06-07 | TRIL | Sale | 3,646 | 8.27 | 30,152 |
| 2021-05-07 | TRIL | Sale | 3,646 | 9.30 | 33,907 |
| 2021-05-07 | TRIL | Option Ex | 3,646 | .31 | 1,141 |
| 2021-04-07 | TRIL | Option Ex | 3,646 | .30 | 1,097 |
| 2021-04-07 | TRIL | Sale | 3,646 | 10.82 | 39,449 |
| 2021-03-12 | TRIL | Sale | 2,917 | 11.97 | 34,916 |
| 2021-03-12 | TRIL | Option Ex | 2,917 | 3.39 | 9,894 |
| 2021-03-08 | TRIL | Option Ex | 3,646 | .30 | 1,093 |
| 2021-03-08 | TRIL | Sale | 3,646 | 10.11 | 36,861 |
| 2021-02-08 | TRIL | Option Ex | 6,563 | 1.81 | 11,852 |
| 2021-02-09 | TRIL | Option Ex | 584 | 9.62 | 5,618 |
| 2021-02-08 | TRIL | Sale | 6,563 | 12.65 | 83,021 |
| 2021-02-09 | TRIL | Sale | 584 | 14.12 | 8,248 |
| 2021-01-11 | TRIL | Sale | 584 | 15.20 | 8,878 |
| 2021-01-11 | TRIL | Option Ex | 584 | 9.57 | 5,587 |
| 2021-01-08 | TRIL | Option Ex | 8,517 | 7.17 | 61,066 |
| 2021-01-08 | TRIL | Sale | 8,517 | 15.66 | 133,384 |
| 2021-01-07 | TRIL | Sale | 3,646 | 14.75 | 53,782 |
| 2021-01-07 | TRIL | Option Ex | 3,646 | .30 | 1,090 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Uger Robert (Chief Scientific Officer of Trillium Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.